ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $19,000 | +18.8% | 1,211 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +100.0% | 1,211 | 0.0% | 0.00% | – |
| Q2 2016 | $8,000 | -93.1% | 1,211 | -90.1% | 0.00% | – |
| Q1 2016 | $116,000 | -4.1% | 12,230 | +2.1% | 0.00% | – |
| Q4 2015 | $121,000 | -28.8% | 11,983 | +0.7% | 0.00% | – |
| Q3 2015 | $170,000 | – | 11,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ground Swell Capital, LLC | 25,445 | $19,000 | 0.05% |
| ETF MANAGERS GROUP, LLC | 2,258,970 | $1,654,000 | 0.05% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 116,780 | $85,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 131,036 | $96,000 | 0.01% |
| Bernardo Wealth Planning LLC | 30,469 | $20,000 | 0.01% |
| PCG Wealth Advisors, LLC | 15,200 | $12,000 | 0.00% |
| Penserra Capital Management LLC | 212,298 | $155,000 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $36,000 | 0.00% |
| King Wealth Management Group | 16,000 | $12,000 | 0.00% |
| Vident Investment Advisory, LLC | 105,398 | $77,000 | 0.00% |